Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. Stock

Equities

605016

CNE1000052N4

Food Processing

End-of-day quote Shanghai S.E. 2024-12-03 5-day change 1st Jan Change
16.64 CNY -0.72% Intraday chart for Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. +2.84% -23.80%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions on site

Valuation: Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.

Capitalization 5.38B 738M 702M 654M 583M 1.04B 62.51B 1.14B 8.13B 3.01B 25.63B 2.77B 2.71B 110B P/E ratio 2024 *
19.8x
P/E ratio 2025 * 14.7x
Enterprise value 5.38B 738M 702M 654M 583M 1.04B 62.51B 1.14B 8.13B 3.01B 25.63B 2.77B 2.71B 110B EV / Sales 2024 *
4.49x
EV / Sales 2025 * 3.44x
Free-Float
29.86%
Yield 2024 *
0.65%
Yield 2025 * 0.67%
More valuation ratios * Estimated data
Dynamic Chart
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024 Oct. 30 CI
Bailong Chuangyuan Co., Ltd. announced that it has received THB 105 million in funding from Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. Oct. 10 CI
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.(XSSC:605016) added to S&P Global BMI Index Sep. 22 CI
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024 Jul. 09 CI
Bailong Chuangyuan Bio-Tech Completes Dietary Fiber Plant Construction May. 29 MT
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 Apr. 26 CI
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 Feb. 27 CI
Bailong Chuangyuan Bio-tech to Build 452 Million Yuan Thai Factory 23-10-23 MT
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 23-10-20 CI
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 23-08-03 CI
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 23-04-27 CI
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 22-10-28 CI
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 22-07-21 CI
More news
1 day-0.72%
1 week+2.84%
Current month+0.67%
1 month-3.48%
3 months-0.30%
6 months-29.15%
Current year-23.80%
More quotes
1 week
16.00
Extreme 16
17.05
1 month
15.66
Extreme 15.66
19.33
Current year
14.54
Extreme 14.54
23.96
1 year
14.54
Extreme 14.54
23.96
3 years
9.86
Extreme 9.8587
23.96
5 years
6.88
Extreme 6.8838
23.96
10 years
6.88
Extreme 6.8838
23.96
More quotes
Director TitleAgeSince
Chief Executive Officer 46 2018-06-17
Director of Finance/CFO 46 2017-03-31
Corporate Officer/Principal 47 2006-05-31
Manager TitleAgeSince
Director/Board Member 59 2022-09-18
Director/Board Member 59 2016-09-24
Director/Board Member 62 2016-09-24
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
-0.72%+2.84%-21.88%+47.78%738M
+0.28%-1.82%-23.17%-15.88%2.32B
+10.00%+5.82%+279.29%+254.00%2.14B
0.00%+1.03%-2.97%-25.19%1.85B
-2.87%+4.26%+26.18%+86.59%1.45B
-0.60%-1.18%-24.50%-28.11%1.37B
+1.30%+0.18%-2.32%+39.90%1.1B
-0.95%-0.21%-15.28%+69.27%1.09B
+1.13%+2.87%+4.26%+95.27%1.04B
0.00%+6.31%+1.81%-7.16%849M
Average +0.76%+3.56%+22.14%+51.65% 1.4B
Weighted average by Cap. +1.30%+3.97%+36.86%+57.03%
See all sector performances

Financials

2024 *2025 *
Net sales 1.2B 164M 156M 146M 130M 231M 13.91B 254M 1.81B 671M 5.71B 617M 603M 24.56B 1.56B 214M 204M 190M 169M 301M 18.15B 331M 2.36B 875M 7.44B 805M 787M 32.03B
Net income 271M 37.24M 35.43M 33M 29.42M 52.39M 3.15B 57.52M 410M 152M 1.29B 140M 137M 5.57B 365M 50.15M 47.7M 44.44M 39.61M 70.54M 4.25B 77.45M 552M 205M 1.74B 188M 184M 7.5B
Net Debt - -
More financial data * Estimated data
Logo Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.
Shandong Bailong Chuangyuan Bio-Tech Co Ltd is a China-based company mainly engaged in food additives. The Company's main businesses include prebiotic series products, mainly including fructooligosaccharides, isomalt oligosaccharides, galacto-oligosaccharides, xylo-oligosaccharides; dietary fiber series products, mainly including resistant dextrin and polydextrose; other starch sugar (alcohol) products, mainly including maltitol, fructose syrup, and maltose syrup; and healthy sweetener products, mainly for the research and development, production and sales of allulose. The Company's main products are widely used in food, dairy products, infant milk powder, functional beverages, health care products, medicine, animal nutrition and feed industries.
Employees
742
More about the company
Date Price Change Volume
24-12-03 16.64 ¥ -0.72% 2,073,360
24-12-02 16.76 ¥ +1.39% 2,950,582
24-11-29 16.53 ¥ +2.61% 2,431,320
24-11-28 16.11 ¥ -1.47% 1,553,200
24-11-27 16.35 ¥ +1.05% 1,917,467

End-of-day quote Shanghai S.E., December 02, 2024

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
surperformance-ratings-light-chart SHANDONG-BAILONG-CHUANGYUMore Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
16.64CNY
Average target price
22.75CNY
Spread / Average Target
+36.72%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 605016 Stock
Exceptional Extension | BLACK FRIDAY -40% : Unlock Tomorrow's Top Investments with Our Exclusive Subscriber-Only Tools!
d
:
:
BENEFIT NOW